The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
250 jobs Number of planned job creations
Announcement Date
7 March 2022
Employment effect (start)
1 March 2022
Foreseen end date
Description
GSK (GlaxoSmithKline), the British multinational pharmaceutical company and the biggest employer in the Belgian Region of Wallonia, is to create 250 new jobs. The company is looking for researchers to support the development of 20 new vaccines, but also for roles in production and export of existing vaccines (influenza, polio, meningitis). GSK has also launched a recruitment day.
Currently, GSK employs 9,000 people in Belgium. The company distributes around 600 million doses of vaccines in more than 160 countries.
Eurofound (2022), GlaxoSmithKline, Business expansion in Belgium, factsheet number 106468, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/106468.